Cargando…
Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients
BACKGROUND: Gender-based differences in disease onset in murine models of malignant peripheral nerve sheath tumor (MPNST) and in patients with Neurofibromatosis type-1-(NF-1)-associated or spontaneous MPNST has not been well studied. METHODS: Forty-three mGFAP-Cre+;Pten(loxp/+);LSL-K-ras(G12D/+) mic...
Autores principales: | Shurell, Elizabeth, Tran, Linh M, Nakashima, Jonathan, Smith, Kathleen B, Tam, Brenna M, Li, Yunfeng, Dry, Sarah M, Federman, Noah, Tap, William D, Wu, Hong, Eilber, Fritz C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237782/ https://www.ncbi.nlm.nih.gov/pubmed/25398666 http://dx.doi.org/10.1186/1471-2407-14-827 |
Ejemplares similares
-
Characterizing the immune microenvironment of malignant peripheral nerve sheath tumor by PD-L1 expression and presence of CD8+ tumor infiltrating lymphocytes
por: Shurell, Elizabeth, et al.
Publicado: (2016) -
Comprehensive adipocytic and neurogenic tissue microarray analysis of NY-ESO-1 expression - a promising immunotherapy target in malignant peripheral nerve sheath tumor and liposarcoma
por: Shurell, Elizabeth, et al.
Publicado: (2016) -
Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model
por: Yamamoto, Mako, et al.
Publicado: (2016) -
Rexin-G(®), a tumor-targeted retrovector for malignant peripheral nerve sheath tumor: A case report
por: Kim, Seth, et al.
Publicado: (2017) -
FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after Neoadjuvant Therapy in Adult Primary Bone Sarcomas
por: Benz, Matthias R., et al.
Publicado: (2010)